Danaher (DHR) Capital Expenditures Growth (1y) (2010 - 2026)
Danaher (DHR) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | 53.06% |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | 8.47% |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | -27.73% |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | -33.33% |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | 31.13% |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | 1.48% |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | 33.33% |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | 16.40% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 27.78% |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | -3.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 26, 2026 | 8.47% |
| Mar 27, 2026 | -3.27% |
| Dec 31, 2025 | -28.10% |
| Sep 26, 2025 | -2.01% |
| Jun 27, 2025 | -13.59% |
| Mar 28, 2025 | -15.81% |
| Dec 31, 2024 | 18.89% |
| Sep 27, 2024 | -15.82% |
| Jun 28, 2024 | -12.77% |
| Mar 29, 2024 | 9.40% |
| Dec 31, 2023 | 47.12% |
| Sep 29, 2023 | 27.80% |
| Jun 30, 2023 | 11.15% |
| Mar 31, 2023 | 6.40% |
| Dec 31, 2022 | -19.40% |
| Sep 30, 2022 | -12.89% |
| Jul 1, 2022 | -2.95% |
| Apr 1, 2022 | -0.40% |
| Dec 31, 2021 | 15.82% |
| Oct 1, 2021 | 70.05% |